How I diagnose and manage VEXAS syndrome

A Hagiya, IN Siddiqi, E Wang… - American Journal of …, 2024 - academic.oup.com
Objectives To discuss VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic)
syndrome, including the clinical and pathologic features, diagnostic challenges, and …

Venous and arterial thrombosis in patients with VEXAS syndrome

Y Kusne, A Ghorbanzadeh, A Dulau-Florea… - Blood, 2024 - ashpublications.org
Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome,
caused by somatic mutations in UBA1, is an autoinflammatory disorder with diverse systemic …

VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation

I Kötter, M Krusche - Current Opinion in Rheumatology, 2025 - journals.lww.com
In the current review, we discuss the novelties for VEXAS, including pathogenic pathways,
epidemiological data, diagnostic criteria and algorithms, treatment options and …

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field

L Phan, D Hammond, NR Wilson… - Leukemia & …, 2024 - Taylor & Francis
VEXAS syndrome is a recently described entity characterized by systemic inflammatory and
hematologic manifestations. The disease was first characterized by Beck et al. in 2020 in a …

VEXAS syndrome diagnosis starting from ultrasound findings: a case report

T Rácz, S Burciu, T Torok, L Damian… - Medical …, 2024 - medultrason.ro
VEXAS syndrome is a recently described condition characterized by systemic inflammation,
predisposition to hematologic malignancy and a high rate of venous thrombosis. Here we …

VEXAS syndrome and thrombosis: findings of inflammation, hypercoagulability, and endothelial dysfunction

BE Fan, CLL Sum, BPL Leung, MK Ang… - … in Thrombosis and …, 2024 - thieme-connect.com
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a novel
autoinflammatory syndrome due to a ubiquitin like modifier activating enzyme 1 (UBA1) …

Aspects cliniques diagnostiques et thérapeutiques du syndrome VEXAS

P Breillat, B Terrier - Bulletin de l'Académie Nationale de Médecine, 2025 - Elsevier
Résumé VEXAS est un acronyme (vacuoles, enzyme E1, lié à l'X, auto-inflammatoire,
somatique) qui désigne un syndrome auto-inflammatoire décrit pour la première fois en …

OP0243 EFFICACY AND SAFETY OF TARGETED THERAPIES IN VEXAS SYNDROME: RETROSPECTIVE STUDY FROM THE FRENVEX

J Hadjadj, Y Nguyen, D Mouloudj, R Bourguiba… - 2024 - ard.bmj.com
Background: VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome
is an autoinflammatory disease of adults associated with somatic mutations in the UBA1 …

VEXAS syndrome: from a vascular perspective

AF Guédon - Blood, 2024 - ashpublications.org
The use of TKIs (first imatinib, followed by second-and third-generation TKIs) in combination
with conventional chemotherapy in children and young adults, or with reduced intensity in …

VEXAS-Syndrom: Paradigmenwechsel in der Differenzialdiagnose: Neues, eher häufiges autoentzündliches Krankheitsbild

K Thürmel - hautnah dermatologie, 2024 - Springer
Als Autoinflammation bezeichnet man unphysiologische entzünd liche Prozesse im Körper,
die nicht auf einer Immunantwort des adap tiven Immunsystems basieren, sondern …